GENERAL ORTHOPAEDICS
Thromboprophylaxis with enoxaparin for 20 days postdischarge reduced incidence of DVT
Arthroscopy. 2007 Jul;23(7):696-702175 patients who have undergone arthroscopic ACL surgery and had been administered enoxaparin starting 12-18 hours post-op until 3-8 days post-op in the hospital, were randomized to either self-administer enoxaparin for 20 additional days postdischarge, or self-administer a placebo for 20 days postdischarge. The results indicated that postdischarge throbmoprophylaxis for an extended period of 20 days resulted in reduced incidence of DVT, compared to thromboprophylaxis in-hospital for only 3-8 days.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
